Weight management and cardiovascular risk reduction: The role of Semaglutide 2.4mg
Description
In this Product Explainer, Dr. Robert Hungerford, GP with a special interest in ASCVD, heart failure and diabetes, explains the role of Semaglutide 2.4mg in weight management and cardiovascular risk reduction in secondary prevention (7 mins).
NEXT LIVE Webcast
:
Days
:
Hours
:
Minutes
Seconds
Prof Deborah Bateson AM
The Natural Estrogen Debate: A Focus on Combined Oral Contraception
Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm
Panel Discussion on GLP1s for Chronic Kidney Disease in Type 2 Diabetes
Dr Gabby Mahoney
Eczema Management Practical Tips
Prof Rodney Baber AM
Menopausal Hormone Therapy and its Cardiovascular Benefits
Join us for the next free webcast for GPs and healthcare professionals
High quality lectures delivered by leading independent experts
